FINETECH PHARMACEUTICAL LTD

Overview

FINETECH PHARMACEUTICAL LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering CABERGOLINE DRUG SUBSTANCE; DONEPEZIL HYDROCHLORIDE; ERIBULIN MESYLATE DRUG SUBSTANCE; FINEMOX CV 625 (CO- AMOXICLAV TABLETS BP 625 MG); LATANOPROST DRUG SUBSTANCE; NABILONE.

API / Drug Master Files

FINETECH PHARMACEUTICAL LTD holds 6 active (7 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ERIBULIN MESYLATE DRUG SUBSTANCEActive2024-07-14
• NABILONEActive2017-08-14
• FINEMOX CV 625 (CO- AMOXICLAV TABLETS BP 625 MG)Active2013-01-29
• LATANOPROST DRUG SUBSTANCEActive2006-06-20
• DONEPEZIL HYDROCHLORIDEActive2001-10-29
• CABERGOLINE DRUG SUBSTANCEActive2001-04-30
• TROVOPROST (TOS-00)Inactive2006-01-20

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FINETECH PHARMACEUTICAL LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.